FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| OLYMPIA PHARMACY | 017674368 | 73198-020 | 73198-020-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; 300 ug/1 mL; .2 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| OLYMPIA PHARMACY | 017674368 | 73198-020 | 73198-020-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; 300 ug/1 mL; .2 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Olympia Pharmacy | 73198-020 | 73198-020-03 | QM-4 | Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 300 mcg/mL Atropine Sulfate 0.2 mg/mL | 30 mg/1 mL; 3 mg/1 mL; 300 ug/1 mL; .2 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| Olympia Pharmacy | 73198-020 | 73198-020-10 | QM-4 | Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 300 mcg/mL Atropine Sulfate 0.2 mg/mL | 30 mg/1 mL; 3 mg/1 mL; 300 ug/1 mL; .2 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| OLYMPIA PHARMACY | 017674368 | 73198-020 | 73198-020-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2023-1 | valid | 2026-10-06 | |
| OLYMPIA PHARMACY | 017674368 | 73198-020 | 73198-020-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2022-2 | valid | 2026-10-06 | |
| OLYMPIA PHARMACY | 017674368 | 73198-020 | 73198-020-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2022-2 | valid | 2026-10-06 |